DARPA Awards up to $10.7 Million Contract to RxMP Therapeutics, Inc.

The Quick Take
Award will support completion of IND-enabling development and manufacturing scale-up of RMP-402 under DARPA's RAPIID program SEATTLE, Oct. 20, 2026 /PRNewswire/ -- RxMP Therapeutics, Inc. ("RxMP"), a late pre-clinical stage therapeutics company developing novel therapies for the rapid...
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire.



